| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/22/2003 | EP1222459A4 Crystallographic structure of the androgen receptor ligand binding domain |
| 01/22/2003 | EP1161142A4 Methods for culturing fluid-filled sensory organs |
| 01/22/2003 | EP1107980B1 CRYSTALLINE FORMS OF EtO2C-CH2-(R)Cgl-Aze-Pab-OH |
| 01/22/2003 | EP1017405A4 Therapeutic hemoglobin composition having isotropically increased size |
| 01/22/2003 | EP0973901B1 Flip gene and flip protein |
| 01/22/2003 | EP0963207A4 Il-12 gene therapy of tumors |
| 01/22/2003 | EP0942721B1 Liquid composition comprising an hiv protease inhibitor and a c12-c18 fatty acid |
| 01/22/2003 | EP0909174A4 Treatment of cystic disease with tnf-alpha |
| 01/22/2003 | EP0873423A4 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 01/22/2003 | EP0865339B1 Metalloproteinase inhibitors |
| 01/22/2003 | EP0854731B1 Copolymeric micelle drug composition and method for the preparation thereof |
| 01/22/2003 | EP0725647A4 Using lectins for contraception, prophylaxis and therapy |
| 01/22/2003 | EP0635028B1 Pulmonary surfactant protein fragments |
| 01/22/2003 | CN1392798A Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising same |
| 01/22/2003 | CN1392797A High mannose proteins and method of making mannose proteins |
| 01/22/2003 | CN1392264A Process for preparing easy body absorption protein ion and health food produced therefrom |
| 01/22/2003 | CN1392263A Method for preparing easy body absorption protein-calcium by enzyme and health food produced by said protein-calcium |
| 01/22/2003 | CN1392158A Pentadeca-peptide capable of specifically binding with intercellular adhesion molecule-1 |
| 01/22/2003 | CN1392157A New anti-embolism medicine using small peptide arginine-glycine-aspartic acid (RGD) as leading compound |
| 01/22/2003 | CN1392156A Synthesizing method for propyl-glutdipeptide |
| 01/22/2003 | CN1391953A Biological food therapeutic health article containing metallothionein for treating diabetes and complication and its preparation |
| 01/22/2003 | CN1391899A Aseptic freeze-dried prostaglandin injection and its preparing method and use |
| 01/22/2003 | CN1391880A Electric moxibustion instrument |
| 01/22/2003 | CN1099462C Medical composition |
| 01/22/2003 | CN1099425C 新的肽衍生物 New peptide derivatives |
| 01/21/2003 | WO2004009834A2 Novel nucleic acids and secreted polypeptides |
| 01/21/2003 | US6509515 Transgenic mice expressing mutant human APP and forming congo red staining plaques |
| 01/21/2003 | US6509460 Nucleoside triphosphates and their incorporation into oligonucleotides |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509449 To provide a detection method for assaying the polypeptide using the monoclonal antibody |
| 01/21/2003 | US6509448 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509445 Effective metastasis inhibitory actions based on combined properties of two proteins; cancerous metastasis inhibitor with lower toxicity |
| 01/21/2003 | US6509444 Serum amyloid a isoform from colostrum |
| 01/21/2003 | US6509443 Amino acid residue located at position 63 of native-sequence human Insulin like Growth Factor-I is replaced with an alanine residue or amino acid residues at positions 1 and 70 are replaced with serine and valine respectively |
| 01/21/2003 | US6509371 Compositions containing Bergamottin for increasing the oral bioavailability of pharmaceutical agents |
| 01/21/2003 | US6509330 Angiotensin converting enzyme (ACE); neutral endopeptidase (NEP); containing a dipeptide derived from an amino acid, or a conformationally restricted dipeptide mimic |
| 01/21/2003 | US6509321 Treatment of Kaposi's sarcoma with IL-12 |
| 01/21/2003 | US6509318 TGF-B inhibitors and methods |
| 01/21/2003 | US6509317 Administering a therapeutically effective amount of a bactericidal/permeability-increasing (BPI) protein product to patient exhibiting elevated levels of lipopolysaccharides |
| 01/21/2003 | US6509316 Administering therapeutically effective amount of inhibitor of phospholipase A2 to animal |
| 01/21/2003 | US6509315 Didemnin analogs and fragments and methods of making and using them |
| 01/21/2003 | US6509314 Methods of preventing or reducing scarring with decorin or biglycan |
| 01/21/2003 | US6509313 Stimulation of immune response with low doses of cytokines |
| 01/21/2003 | US6509189 Nucleic acid molecules encoding the cytoplasmic domain of human Ob receptor |
| 01/21/2003 | US6509173 Related members of a broad class of polypeptide mediators, which includes the interferons, interleukins and growth factors, collectively called cytokines |
| 01/21/2003 | US6509167 High throughput sarcomeric assay |
| 01/21/2003 | US6509165 Detecting the ability of proinsulin peptide to preferentially stimulate the T-cells of diabetic subjects by measuring the ability of the T-cells to proliferate or ability of the T-cells to produce cytokines |
| 01/21/2003 | US6509162 Methods for selectively modulating survivin apoptosis pathways |
| 01/21/2003 | US6509155 Characterization, diagnosis, prevention, and treatment of cell signaling, immune, and cell proliferative disorders, particularly colon cancer |
| 01/21/2003 | US6509154 Product comprising at least a double stranded RNA combined with at least an antiviral agent |
| 01/21/2003 | US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages |
| 01/21/2003 | US6509149 HPV-specific oligonucleotides |
| 01/21/2003 | US6509043 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of pulmonary diseases |
| 01/21/2003 | US6509033 Immunomodulatory peptides |
| 01/21/2003 | US6509020 Replication-competent herpes simplex virus |
| 01/21/2003 | US6509019 Immunologically active proteins from Borrelia burgdorferi |
| 01/21/2003 | US6509015 Human antibodies that bind human TNFa |
| 01/21/2003 | US6509014 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discreet erythema |
| 01/21/2003 | US6509006 Readily and reliably dispersible dry powder biocompatible particles of alpha-1-antitrypsin |
| 01/21/2003 | US6509001 Calcitonin receptor binding reagents |
| 01/21/2003 | CA2453344A1 Novel nucleic acids and secreted polypeptides |
| 01/21/2003 | CA2204253C Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 01/21/2003 | CA2106952C A single dose vaccination system |
| 01/21/2003 | CA2098720C Cellular composition for the treatment of human or animal organisms |
| 01/21/2003 | CA1341418C Substantially-pure non-inflammatory hyaluronic acid |
| 01/21/2003 | CA1341417C Hirudine-expressing vectors, altered cells, and a process for hirudine preparation |
| 01/21/2003 | CA1341416C Hirudine variants, their use and preparation process |
| 01/18/2003 | CA2352702A1 Novel human proton gated ion channel |
| 01/17/2003 | CA2352439A1 Engineering oncolytic viruses |
| 01/16/2003 | WO2003005036A2 Epf receptor assays, compounds and therapeutic compositions |
| 01/16/2003 | WO2003005035A1 Chp for use as marker for sepsis-type inflammatory diseases |
| 01/16/2003 | WO2003005034A2 Processes for identifying therapeutic agents useful in treating diseases involving fzd4 gene |
| 01/16/2003 | WO2003004706A1 Glucocorticoid-induced receptor and methods of use |
| 01/16/2003 | WO2003004691A2 Regulators of biofilm formation and uses thereof |
| 01/16/2003 | WO2003004689A2 Regulators of biofilm formation and uses thereof |
| 01/16/2003 | WO2003004685A2 Soluble steroidal peptides for nucleic acid delivery |
| 01/16/2003 | WO2003004680A2 Atherosclerosis susceptibility gene locus 1 (athsq1) and 2 (athsq2) |
| 01/16/2003 | WO2003004660A1 Methods of administering vectors to synaptically connected neurons |
| 01/16/2003 | WO2003004657A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | WO2003004650A2 Group b streptococcus antigens and corresponding dna fragments |
| 01/16/2003 | WO2003004646A2 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 01/16/2003 | WO2003004644A1 Delivery of dsrna to arthropods |
| 01/16/2003 | WO2003004637A1 Utilization of histamine receptor h3 gene participating in body weight or food intake control |
| 01/16/2003 | WO2003004631A2 USE OF INHIBITORS OF EXPRESSION OR ACTIVITY OF p8/com1 FOR TREATING TUMORS. |
| 01/16/2003 | WO2003004628A2 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme |
| 01/16/2003 | WO2003004623A2 Human secreted proteins |
| 01/16/2003 | WO2003004622A2 Human secreted proteins |
| 01/16/2003 | WO2003004618A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/16/2003 | WO2003004615A2 Secreted proteins |
| 01/16/2003 | WO2003004613A2 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | WO2003004612A2 Inhibitor of t cell activation |
| 01/16/2003 | WO2003004609A2 Novel human kielin-like proteins and polynucleotides encoding the same |
| 01/16/2003 | WO2003004608A2 Drug metabolizing enzymes |
| 01/16/2003 | WO2003004607A2 Aggrecanase molecules |
| 01/16/2003 | WO2003004606A2 Antisense oligonucleotides and related methods for regulating cell death |
| 01/16/2003 | WO2003004604A2 Phage displayed pdz domain ligands |
| 01/16/2003 | WO2003004600A2 Improvement of viral uptake into cells and tissues |
| 01/16/2003 | WO2003004595A2 Materials and methods relating to protein and nucleic acid evolution |
| 01/16/2003 | WO2003004533A1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells |